The common and specific osteoarthritis gait characteristics: A quantitative grading system for OA associated gait changes in mice

常见和特异的骨关节炎步态特征:小鼠骨关节炎相关步态改变的定量分级系统

阅读:3

Abstract

OBJECTIVE: Osteoarthritis (OA) severity in animal models has been quantified primarily through grading systems reflecting the changes of joint morphology. There is a lack of a uniform grading system to quantify the changes in motion. Here, we develop a quantitative, easy-to-use grading system for OA-associated gait changes in mice. DESIGN: We characterized the mouse gait changes in a surgery induced post-traumatic OA (PTOA) model and aging-associated OA (aging-OA) models using DigiGait. This treadmill system captured running motions for video analysis. We developed and validated the OA Gait grading system with a quantitative formula indicating the extent of OA-related movement changes. RESULTS: We found gait changes in both aging-OA and PTOA mouse models, consistent with OA cartilage degeneration and increasing OARSI (Osteoarthritis Research Society International) scores. The female aging-OA and male PTOA mice share common gait alterations including a significant decrease in stride time and stride length and a significant increase in stride frequency. These three gait changes compose the "Common OA Gait" in mice. In addition, aging-OA alters gait symmetry between forelimbs and hindlimbs while PTOA alters ataxia coefficient between left and right limbs. These "Specific OA Gait" may indicate the involvement of aging and/or injury in OA pathogenesis. CONCLUSIONS: The OA Gait grading system correlated with OA pathogenesis. In some instances of aging-OA, it preceded the histopathological changes indicated by the OARSI grading system. Thus, the OA Gait grading system may be widely used for detecting alteration of functional movement outcomes in a sensitive, quantitative, and mechanistic manner.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。